33rd WHO Regulatory Update on COVID-19

Overview

Investing in sustainable secure manufacturing capacity and national regulatory authorities is critical for providing essential immunization programmes and for building strong, resilient health systems against the inevitable health emergencies of the future. To address this challenge, WHO and partners have established a COVAX Manufacturing Task Force to increase supply in the short-term but also to build a platform for sustainable vaccine manufacturing to support regional health security in the long-term.